The concept of hypoallergenicity for atopy prevention

Andrea von Berg1

  • 1Research Institute for the Prevention of Allergies and Respiratory Diseases, Children's Department, Marien-Hospital Wesel, Pastor-Janssen-Strasse 8-38, DE-46483 Wesel, Germany. vonberg@marien-hospital-wesel.de

Insights

Hydrolyzed infant formulas can help prevent allergies in high-risk infants. These formulas reduce cow

Area of Science:

  • Pediatrics
  • Immunology
  • Allergy Research

Background:

  • Infancy is a critical period for sensitization, with 2.5% of neonates experiencing hypersensitivity to cow's milk protein.
  • Early cow's milk exposure is strongly linked to hypersensitivity reactions in infants.
  • Preventing allergic diseases involves strategies like reduced allergenicity diets and oral tolerance induction.

Purpose of the Study:

  • To evaluate the efficacy of hydrolyzed infant formulas in preventing allergic diseases.
  • To explore the role of reduced allergenicity and oral tolerance in infant allergy prevention.

Main Methods:

  • Review of clinical studies on partially and extensively hydrolyzed infant formulas.
  • Analysis of in vitro allergenicity characterization versus in vivo immunogenic effects.
  • Investigation of the manufacturing process's impact on formula efficacy.

Main Results:

  • Hydrolyzed infant formulas are recommended for high-risk infants during the first 4-6 months.
  • Both partially and extensively hydrolyzed formulas show potential in preventing atopic eczema and food allergy.
  • Preventive effects may depend more on the hydrolyzation process than the degree of hydrolysis.

Conclusions:

  • Hydrolyzed infant formulas are effective in reducing the risk of allergic diseases in infants.
  • The manufacturing process may influence the induction of tolerogenic epitopes, enhancing preventive effects.
  • Further research into specific processing methods is warranted.

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Cross-reactivity00:42

Cross-reactivity

Overview